Endoscopic indigo carmine spraying for evaluation of intestinal mucosal permeability: Prospective pilot study

Abstract

Background and study aims

"Leaky gut," caused by increased mucosal permeability, plays a pivotal role in various diseases. However, few methods are available to evaluate intestinal mucosal permeability in the living human body. We established a novel method for evaluation of mucosal permeability using indigo carmine (IC).

Patients and methods

Subjects undergoing colonic endoscopy for screening of colon polyps or evaluation of ulcerative colitis (UC) severity were enrolled. IC was endoscopically sprayed in the cecum, and blood samples were obtained before spraying and at 30 and 60 minutes after. Serum IC level was analyzed by liquid chromatographer/mass spectrometer equipped with a Nexera HPLC system.

Results

In both the control (subjects screened for colon polyps) and UC groups, all subjects had their highest serum IC levels at 30 minutes after spraying. Serum IC level was significantly higher in UC patients than in the controls at both 30 and 60 minutes after spraying. In the UC group, serum IC levels at both 30 and 60 minutes were significantly higher in patients with a Mayo endoscopic subscore (MES) 1 at the cecum than in those with MES 0 in the same area.

Conclusions

Endoscopic spraying with IC is useful for evaluation of intestinal mucosal permeability.

Keywords

Endoscopy Lower GI Tract - Inflammatory bowel disease - Diagnosis and imaging (inc chromoendoscopy, NBI, iSCAN, FICE, CLE...)

• References

• 1 Motta JP, Wallace JL, Buret AG. et al. Gastrointestinal biofilms in health and disease. Nat Rev Gastroenterol Hepatol 2021; 18: 314-334
• 2 Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol 2024; 24: 577-595
• 3 Ross FC, Patangia D, Grimaud G. et al. The interplay between diet and the gut microbiome: implications for health and disease. Nat Rev Microbiol 2024; 22: 671-686
• 4 Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9: 799-809
• 5 Ahmad R, Sorrell MF, Batra SK. et al. Gut permeability and mucosal inflammation: bad, good or context dependent. Mucosal Immunol 2017; 10: 307-317
• 6 Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut 2019; 68: 1516-1526
• 7 Wu X, Xu J, Li J. et al. Bacteroides vulgatus alleviates dextran sodium sulfate-induced colitis and depression-like behaviour by facilitating gut-brain axis balance. Front Microbiol 2023; 14: 1287271
• 8 Luo L, Zhao Y, Zhang G. et al. Tauroursodeoxycholic acid reverses dextran sulfate sodium-induced colitis in mice via modulation of intestinal barrier dysfunction and microbiome dysregulation. J Pharmacol Exp Ther 2024; 390: 116-124
• 9 Fukui H, Oshima T, Tanaka Y. et al. Effect of probiotic Bifidobacterium bifidum G9–1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats. Sci Rep 2018; 8: 12384
• 10 Ran Y, Fukui H, Xu X. et al. Alteration of colonic mucosal permeability during antibiotic-induced dysbiosis. Int J Mol Sci 2020; 21: 6108
• 11 Nakanishi T, Fukui H, Wang X. et al. Effect of a high-fat diet on the small-intestinal environment and mucosal integrity in the gut-liver axis. Cells 2021; 10: 3168
• 12 Nakase H, Uchino M, Shinzaki S. et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol 2021; 56: 489-526
• 13 Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987; 317: 1625-1629
• 14 Barreiro-de Acosta M, Vallejo N, Iglesia D. et al. Evaluation of the risk relapse in ulcerative colitis according to the degree of mucosal healing (Mayo 0 vs 1): A longitudinal cohort study. J Crohns Colitis 2016; 10: 13-19
• 15 Farhadi A, Gundlapalli S, Shaikh M. et al. Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int 2008; 28: 1026-1033
• 16 Tomita T, Fukui H, Morishita D. et al. Diarrhea-predominant irritable bowel syndrome-like symptoms in patients with quiescent Crohn's disease: Comprehensive analysis of clinical features and intestinal environment including the gut microbiome, organic acids, and intestinal permeability. J Neurogastroenterol Motil 2023; 29: 102-112
• 17 Kiesslich R, Duckworth CA, Moussata D. et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 2012; 61: 1146-1153
• 18 Chang J, Leong RW, Wasinger VC. et al. Impaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healing. Gastroenterology 2017; 153: 723-731 e1
• 19 Rath T, Atreya R, Bodenschatz J. et al. Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in inflammatory bowel disease: The prospective ERIca trial. Gastroenterology 2023; 164: 241-255
• 20 Fritscher-Ravens A, Schuppan D, Ellrichmann M. et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology 2014; 147: 1012-1020 e4